Stockreport

Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States

AKERS BIOSCIENCES INC COMMON S  (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF THOROFARE, N.J.,, July 18, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health in [Read more]